Image

Dr Alexander Veith

Partner

Email

alexander.veith@aoshearman.com

Phone

+49 89 71043 3120

Offices

Munich

V-CARD
Alexander is Germany Life Sciences Sector Lead. He specializes in national and cross-border M&A transactions with a particular focus on the Life Sciences and the Technology sectors.
Alexander also advises clients on a wide variety of matter, including venture capital investments, joint ventures and complex corporate reorganisations. Alexander regularly advises clients on M&A auction processes, executing successful transactions both for sellers and for buyers.

Alexander’s clients comprise national and international corporates, PE clients as well as VC investors. He has more than 20 years experience with M&A transactions. Alexander´s clients appreciate his efficient and pragmatic way of working.

Experience

Representative matters

  • A healthcare information, services and technology company in relation to the acquisition of DAVASO, a leading service provider for statutory health insurers in Germany with a focus on claims processing, auditing and billing services.
  • Enovis Corporation on the acquisition of a stake in German start-up Orthopy Health GmbH.
  • Vision Healthcare, a fast-growing European online platform for food supplements, cosmetics and health products, on the share purchase agreement with the shareholder of Vitamaze GmbH for the acquisition of 100% of shares in Vitamaze GmbH.
  • Vision Healthcare on the acquisition of 100% of the shares in AixSwiss BV.
  • iOmx Therapeutics AG, a biopharmaceutical company developing cancer immunotherapies based on next-generation immune checkpoint targets, on a Series B financing round of EUR65m.
  • DOCTOR SE in the expansion and implementation of a growth strategy in Germany, including related regulatory aspects.
  • A global healthcare company on a strategic cooperation with German biotech company Curevac.
  • Curaeos, a platform of dental clinics in Germany, Netherlands, Belgium, Denmark and Italy, on its market entry into Germany including on the acquisition of a hospital and various dental practices in Germany.
  • A multinational medical technology company in connection with a cloud-based digital healthcare platform in several EU und non-EU countries.
  • A Japanese pharmaceutical company in an envisaged strategic acquisition.
  • A German pharma company on the intended sale of its allergy business by way of a global carve-out.
  • SAP SE on the acquisition of Kausa technology, an advanced analytics SaaS platform based on machine learning, from The Why Company.
  • SAP SE on its investment in Aleph Alpha GmbH, one of the market leaders in the field of generative AI.
  • SAP SE on the acquisition of LeanIX, a provider of Software-as-a-Service (SaaS) solutions for managing Enterprise Architecture and multi-cloud environments. SAP SE on the acquisition of Signavio GmbH in a 100% share deal. Signavio is a leading provider of enterprise business process intelligence and process mining space.
  • SAP SE on the agreement to acquire Emarsys, a leading provider of omnichannel customer engagement platforms in the cloud.
  • A multinational technology company on the acquisition of Lofelt GmbH, a Berlin-based software start-up for haptic effects.
  • PayPal on its proposed investment in German fintech dwins GmbH (Finanzguru).
  • TripActions, a company for travel, corporate card and expense management based in Palo Alto, California, on the acquisition of all shares in Berlin-based Comtravo GmbH.
  • Elmos Semiconductor SE on the sale of Silicon Microstructures Inc. to TE Connectivity.
  • Elmos Semiconductor SE on the sale of its Dortmund wafer fabrication operations to Littelfuse, Inc.
  • A joint-stock company on a joint venture with and venture capital investment in Volocopter GmbH.
  • Khazanah, a wealth fund of the Government of Malaysia on the acquisition of a stake in Auto1Group start-up, a Europe-wide online marketplace for used cars. Founded in 2012, Auto1Group is valued at almost EUR3bn.
  • Bencis Capital Partners on an investment in steel construction company Gebhardt-Stahl.
  • Bencis Capital Partners on its acquisition of Halex Holding group from H2 Equity Partners.
  • HALEX Holding GmbH, a portfolio company of private equity investor Bencis Capital Partners, on the sale of its toolmaking division (HALEX Extrusion Dies) in Germany and in Italy to Canadian Exco Technologies Limited. We also advised on the carve-out of the target companies from the existing financing (including security release).
  • HR Group and capiton on the sale of the RENO retail companies.
  • Bilfinger on the carve-out and subsequent sale of its concession’s portfolio in the US, Canada, Norway, England, Northern Ireland and Australia.
  • Bilfinger on the sale of its branch in Peitz, which is active in the service business for power plants, and the shares in Bilfinger Babcock Kraftwerkservice, which is active in personnel leasing.
  • Bilfinger on the sale of Bilfinger Marine & Offshore Systems GmbH, the business unit for the installation of offshore windparks.
  • Enercon on the carve-out of its windfarm business and establishment of a windfarm joint venture with EWE Aktiengesellschaft.
  • Recticel, the Belgium-based producer of foams and synthetic compounds, on the acquisition of the foam division of Conzzeta AG.
  • Asamer Group on its restructuring and sale of non-core assets including carve-outs.

Published Work

  • Veith A. (2012) "Verschaerfung von Ad-hoc-Meldepflichten bei gestreckten Entscheidungsprozessen", Der Betrieb, 16/2012
  • Veith A., Schmid S. (2012) "Abschluss und Beendigung von Beherrschungs- und Gewinnabfuehrungsvertraegen im GmbH-Konzern", Der Betrieb 13/2012, page 728 ff.
  • Veith A. (2009) "Haftung der Mitglieder eines fakultativen GmbH-Aufsichtsrates", Status Recht, 6/2009, page 149
  • Veith A. (2007) "Qual der Wahl bei der richtigen Unternehmensform – Ist die Limited eine ernsthafte Alternative zur GmbH?", Sonderausgabe azur
  • Veith A. (2007) "Ein Fortschritt fuer den Mittelstand – Ist die Europaeische Privatgesellschaft das Zukunftsmodell fuer international ausgerichtete Mittelstaendler?", article in FAZ, 17/01/2007
  • Veith A., Fox T. (2006) "Manager auf dem Schleudersitz", Newsletter Private Equity Handelsblatt, 02/2006
  • Veith A., King P. (2005) "GmbH-Reform: Ende einer populistischen Massnahme", Boersen-Zeitung, 14/07/2005
  • Veith A. (2005) "Die Befreiung von der Ad-hoc-Publizitaetspflicht nach §15 Abs. 3 WpHG", NZG, page 254 ff.
  • Veith A., Fox T. (2005) "Private Equity", Corporate Finance Handbuch
  • Veith A. (2003) "Der Glaeubigerschutz beim Formwechsel nach dem Umwandlungsgesetz", Dissertation at University Munich
  • Veith A., Co-Author (2013) "Beck'sches Handbuch Umwandlungen international", C.H.Beck
  • Veith, A. (2014), "Zulässiger Zeitpunkt der Beendigung des Gewinnabführungsvertrags im GmbH-Vertragskonzern", Der Betrieb, page 2156-2157

Speaking Engagements

  • Speaker, Corporate law topics, client events.

Awards

  • Ranked in “Best Lawyers”, Handelsblatt, 2023
  • European M&A Lawyer of the Year, Life Science Awards Europe, 2021
  • “Frequently recommended lawyer”, JUVE Handbuch, 2011-2023
  • “He is extremely impressive and a very good negotiator - he is exactly as you would wish a lawyer to be.”, Chambers Germany 2019
  • “Excellent legal skills, target-oriented and very constructive” (competitor), JUVE Handbuch, 2022/2023

Qualifications

Admissions

Admitted as German Rechtsanwalt, 2002

Academic

Dr iur, Johannes Gutenberg Universität Mainz, Germany, 2002

Second German Law Degree, 2001

First German Law Degree, 1999

Languages

English, German
Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.